| Product Code: ETC6142496 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Myasthenia Gravis Disease Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Myasthenia Gravis Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Myasthenia Gravis Disease Market - Industry Life Cycle |
3.4 Argentina Myasthenia Gravis Disease Market - Porter's Five Forces |
3.5 Argentina Myasthenia Gravis Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Argentina Myasthenia Gravis Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Argentina Myasthenia Gravis Disease Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Argentina Myasthenia Gravis Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 Argentina Myasthenia Gravis Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Argentina Myasthenia Gravis Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of myasthenia gravis in Argentina |
4.2.2 Growing investment in healthcare infrastructure and facilities in the country |
4.2.3 Introduction of advanced treatment options and therapies for myasthenia gravis patients |
4.3 Market Restraints |
4.3.1 High treatment costs associated with managing myasthenia gravis |
4.3.2 Limited access to specialized healthcare services in certain regions of Argentina |
4.3.3 Regulatory challenges and delays in the approval process for new treatments |
5 Argentina Myasthenia Gravis Disease Market Trends |
6 Argentina Myasthenia Gravis Disease Market, By Types |
6.1 Argentina Myasthenia Gravis Disease Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Edrophonium Test, 2021- 2031F |
6.1.4 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.1.5 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Repetitive Nerve Stimulation, 2021- 2031F |
6.1.6 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Single-fiber electromyography (EMG), 2021- 2031F |
6.1.7 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Argentina Myasthenia Gravis Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.3 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2.4 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Immunosuppressants, 2021- 2031F |
6.2.5 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Plasmapheresis, 2021- 2031F |
6.2.6 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Autologous Hematopoietic Stem Cell Transplantation (HSCT), 2021- 2031F |
6.2.7 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3 Argentina Myasthenia Gravis Disease Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Argentina Myasthenia Gravis Disease Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Argentina Myasthenia Gravis Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Onlin Pharmacy, 2021- 2031F |
6.5.4 Argentina Myasthenia Gravis Disease Market Revenues & Volume, By Retail Phrmacy, 2021- 2031F |
7 Argentina Myasthenia Gravis Disease Market Import-Export Trade Statistics |
7.1 Argentina Myasthenia Gravis Disease Market Export to Major Countries |
7.2 Argentina Myasthenia Gravis Disease Market Imports from Major Countries |
8 Argentina Myasthenia Gravis Disease Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for myasthenia gravis patients in Argentina |
8.2 Number of healthcare professionals trained in diagnosing and managing myasthenia gravis |
8.3 Patient adherence rate to prescribed treatment plans |
9 Argentina Myasthenia Gravis Disease Market - Opportunity Assessment |
9.1 Argentina Myasthenia Gravis Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Argentina Myasthenia Gravis Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Argentina Myasthenia Gravis Disease Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Argentina Myasthenia Gravis Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 Argentina Myasthenia Gravis Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Argentina Myasthenia Gravis Disease Market - Competitive Landscape |
10.1 Argentina Myasthenia Gravis Disease Market Revenue Share, By Companies, 2024 |
10.2 Argentina Myasthenia Gravis Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here